CpG-island methylation and epigenetic control of resistance to chemotherapy

Skip Nav Destination

Biochem Soc Trans (2004) 32 (6): 916–917.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer

Myrna Hurtado
Umesh T. Sankpal
Amalendu Ranjan
Rajasekhar Maram
Jamboor K. Vishwanatha
Ganji Purnachandra Nagaraju
Bassel F. El-Rayes
Riyaz Basha

Critical Reviews in Oncology/Hematology (2018) 126: 201.

Vitamin A and the epigenome

Shimrit Bar-El Dadon
Ram Reifen

Critical Reviews in Food Science and Nutrition (2017) 57 (11): 2404.

Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line

Enrico Capobianco
Antonio Mora
Dario La Sala
Annalisa Roberti
Nazar Zaki
Elarbi Badidi
Monia Taranta
Caterina Cinti
Javier S. Castresana

PLoS ONE (2014) 9 (4): e95596.

One-Carbon Metabolism Pathway Gene Variants and Risk of Clear Cell Renal Cell Carcinoma in a Chinese Population

Lei Zhang
Xiaoxin Meng
Xiaobing Ju
Hongzhou Cai
Pu Li
Qiang Cao
Pengfei Shao
Chao Qin
Changjun Yin
Yong-Gang Yao

PLoS ONE (2013) 8 (11): e81129.

Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance

Xiaowei Zhang
Wei Li
Heqing Li
Yanhong Ma
Guangxiang He
Guolin Tan

Anti-Cancer Drugs (2012) 23 (8): 856.

In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer

Therese M. Murphy
Linda Sullivan
Caroline Lane
Lisa O'Connor
Ciara Barrett
Donal Hollywood
Thomas Lynch
Mark Lawler
Antoinette S. Perry

The Prostate (2011) 71 (1): 1.

Modulation of DNA methylation levels sensitizes doxorubicin-resistant breast adenocarcinoma cells to radiation-induced apoptosis

Lidia Luzhna
Olga Kovalchuk

Biochemical and Biophysical Research Communications (2010) 392 (2): 113.

Impact of Genomic Methylation on Radiation Sensitivity of Colorectal Carcinoma

Barbara Hofstetter
Andrzej Niemierko
Christian Forrer
Jean Benhattar
Veronica Albertini
Martn Pruschy
Fred T. Bosman
Carlo V. Catapano
I. Frank Ciernik

International Journal of Radiation Oncology*Biology*Physics (2010) 76 (5): 1512.

Loss of Heterozygosity Combined with Promoter Hypermethylation, the Main Mechanism of Human MutL Homolog (hMLH1) Gene Inactivation in Non-Small Cell Lung Cancer in a Chinese Population

Xin Geng
Fei Wang
Liang Zhang
Wei Ming Zhang

Tumori Journal (2009) 95 (4): 488.

Simultaneous determination of decitabine and vorinostat (Suberoylanalide hydroxamic acid, SAHA) by liquid chromatography tandem mass spectrometry for clinical studies

Katan Patel
Sylvie M. Guichard
Duncan I. Jodrell

Journal of Chromatography B (2008) 863 (1): 19.

The new frontier in cancer research: Deciphering cancer epigenetics

Marion Lohrum
Hendrik G. Stunnenberg
Colin Logie

The International Journal of Biochemistry & Cell Biology (2007) 39 (7-8): 1450.

Biallelic inactivation of hMLH1 by hypermethylation and loss of heterozygosity in non-small cell lung cancer

Xin Geng
Dong Wang
Guoping Zhu
Liang Zhang
Weiming Zhang

Chinese Journal of Clinical Oncology (2006) 3 (3): 162.

Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: Current views and new therapeutic prospective

Annalisa Roberti
Dario La Sala
Caterina Cinti

Journal of Cellular Physiology (2006) 207 (3): 571.

Epigenetic events in medulloblastoma development

Janet C. Lindsey
Jennifer A. Anderton
Meryl E. Lusher
Steven C. Clifford

Neurosurgical Focus (2005) 19 (5): 1.

CpG-island methylation and epigenetic control of resistance to chemotherapy

CONNECT

EXPLORE

CpG-island methylation and epigenetic control of resistance to chemotherapy

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only